Dometuss-dmx Liquid
NDC Package 53809-203-01
Package Information
Dometuss-dmx (guaifenesin, dextromethorphan hbr, phenylephrine hcl) liquids is Do not exceed recommended dosageDo not take more than 4 doses in any 24-hour period age dose Adults and children 12 years of age and older 1 teaspoon every 6 hours Children under 12 years of age ask a doctor . This formulation utilizes a liquid delivery system. Marketed by Domel Laboratories, this product is identified by NDC 53809-203 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1364914 - dextromethorphan HBr 30 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution
- RxCUI: 1364914 - dextromethorphan hydrobromide 6 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution
- RxCUI: 1364914 - dextromethorphan hydrobromide 30 MG / guaifenesin 200 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 53809 - Domel Laboratories
- 53809-203 - Dometuss-dmx
- 53809-203-01 - 30 mL in 1 BOTTLE
- 53809-203 - Dometuss-dmx
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (53809-203). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53809-203-01 identifies a specific commercial package of 30 ml in 1 bottle of Dometuss-dmx, a human over the counter drug labeled by Domel Laboratories. This liquid is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Domel Laboratories on January 21, 2016. The current certification is valid through December 31, 2026.
How is this Domel Laboratories product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53809020301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.